Home Cart Sign in  
Chemical Structure| 347174-05-4 Chemical Structure| 347174-05-4

Structure of Ferrostatin-1
CAS No.: 347174-05-4

Chemical Structure| 347174-05-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ferrostatin-1 is a ferroptosis inhibitor with an IC50 value of 60 nM. Ferrostatin-1 has neuroprotective and antitumor effects and can be used in research on the role of ferroptosis in neurodegenerative diseases and cancer.

Synonyms: Fer-1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ferrostatin-1

CAS No. :347174-05-4
Formula : C15H22N2O2
M.W : 262.34
SMILES Code : O=C(OCC)C1=CC=C(NC2CCCCC2)C(N)=C1
Synonyms :
Fer-1
MDL No. :MFCD08072959
InChI Key :UJHBVMHOBZBWMX-UHFFFAOYSA-N
Pubchem ID :4068248

Safety of Ferrostatin-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Ferroptosis

    Ferroptosis, EC50:60 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
mouse primary microglial cells (mPMs) 10 μM 1 h Inhibited HIV-1 Tat-mediated microglial ferroptosis, reduced lipid peroxidation and the release of proinflammatory cytokines. PMC10106521
H9C2 cells 2 μM reduced DOX-induced cell death by approximately 50% PMC10400469
H9C2 cells 2 μM fully rescued erastin-induced cell death PMC10400469
FHs74Int cells 5 μM 120 h Fer-1 significantly reduced IR-induced cell death and lipid peroxidation levels in the presence of AA PMC10466894
FHs74Int cells 5 μM 72 h Fer-1 significantly reduced IR-induced lipid peroxidation levels in the presence of AA PMC10466894
primary cultured adult mouse cardiomyocytes (PAMCs) 2 μM 48 h To explore whether E-Exe preconditioning of PAMCs could resist DIC injury-induced ferroptosis, results showed that Fer-1 significantly alleviated DIC injury PMC10878110
HTR-8/SVneo cells 5 μM 36 h Blocking ferroptosis significantly reversed the shFTL-induced decrease in cell viability and improved the changes in most ferroptotic marker concentrations/activities. PMC9706170
L02 cells 5 μM 1 h Fer-1 pretreatment significantly increased the protein expression of GPX4 and Ferritin, restored the decreased GSH levels and elevated MDA content caused by EC treatment, and alleviated the cytotoxicity induced by EC. PMC9142717
RD cells 100 μM 36 h Inhibited lipid peroxidation and cell death induced by CV-A6 infection PMC8764547
HUVECs 1 μM 24 h Inhibited ZnONPs-induced cell death and lipid peroxidation PMC8726675
EA.hy926 cells 1 μM 24 h Inhibited ZnONPs-induced cell death and lipid peroxidation PMC8726675
LLC-MK2 cells 40 μM 2-5 days Inhibited lipid peroxidation induced by CoV-229E infection PMC8764547
NRK49F cells 5 μM 1 h Restored GPX4 protein expression PMC9894909
HK-2 cells 5 μM 1 h Restored GPX4 protein expression PMC9894909
ZR-75-1 10 µM 1 h Fer-1 significantly attenuated IR-induced cell death in ER-positive ZR-75-1 cells PMC8888677
oligodendrocytes (OLs) 100 nM Protected oligodendrocytes from cystine deprivation-induced death PMC3985476
HT-1080 fibrosarcoma cells 1 μM 7.5 h Inhibited erastin-induced lipid peroxidation and cell death PMC3985476
human monocyte-derived macrophages 10 µM 4 days inhibited Mtb-induced macrophage necrosis and lipid peroxidation PMC6400546
VSC4.1 cell line 1 μM 12 h To evaluate the protective effect of Ferrostatin-1 on RSL3-induced cell death, it was found that Ferrostatin-1 significantly increased cell viability PMC11103787
HT22 cell line 1 μM 12 h To evaluate the protective effect of Ferrostatin-1 on RSL3-induced cell death, it was found that Ferrostatin-1 significantly increased cell viability PMC11103787
Huc-MSCs 1 μM 24 h To evaluate the effect of Ferrostatin-1 on RSL3-induced intracellular GSH levels, it was found that Ferrostatin-1 significantly increased GSH levels PMC11103787
NRK49F cells 1 μM 1 h Used to inhibit cell death induced by CMPF. The results showed that pretreatment with Ferrostatin-1 significantly reduced ROS production induced by CMPF PMC9894909
HK-2 cells 1 μM 1 h Used to inhibit cell death induced by CMPF. The results showed that pretreatment with Ferrostatin-1 significantly reduced ROS production induced by CMPF PMC9894909
MCF-7 10 µM 1 h Fer-1 significantly attenuated IR-induced cell death in ER-positive MCF-7 and ZR-75-1, but not in ER-negative MDA-MB-231 cells PMC8888677
BMSCs 10 μM 12 h To evaluate the inhibitory effect of Ferrostatin-1 on bacteria-induced ferroptosis in BMSCs. Results showed that Fer-1 significantly reduced the mortality rate of BMSCs and decreased the accumulation of lipid peroxides and ferrous ions. PMC11497072
LO2 cells 10 μM 24 h Inhibited ferroptosis and alleviated CM-IH-induced lipid accumulation and ferroptosis phenotype PMC11538716
HepG2 cells 10 μM 24 h Inhibited ferroptosis and alleviated CM-IH-induced lipid accumulation and ferroptosis phenotype PMC11538716
murine bone marrow-derived macrophages (BMDMs) 10 µM 4 days inhibited Mtb-induced macrophage necrosis and lipid peroxidation PMC6400546
A549 cells 2 μM 2 hours To investigate the effect of iFSP1 on PAM-induced ferroptosis, results showed that iFSP1 enhanced PAM-induced ferroptosis. PMC8901787
H1299 cells 2 μM 2 hours To investigate the effect of iFSP1 on PAM-induced ferroptosis, results showed that iFSP1 enhanced PAM-induced ferroptosis. PMC8901787

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice DOX-induced cardiomyopathy model subcutaneous injection 1 mg/kg daily for 7 days significantly rescued DOX-induced cardiac dysfunction, fibrosis, and oxidative stress PMC10400469
C57BL/6J mice radiation-induced intestinal injury model intraperitoneal injection 5 mg/kg once daily for 14 days Fer-1 significantly improved the survival rate of mice and alleviated radiation-induced intestinal fibrosis PMC10466894
Mice Bone cancer pain model Intraperitoneal injection 10 mg/kg Once daily for 20 consecutive days FER-1 alleviated mechanical allodynia and thermal hyperalgesia in a mouse model of bone cancer pain and reduced spontaneous pain behavior. Furthermore, FER-1 inhibited the pain-associated activation of ERK1/2 and COX-2 expression and prevented the loss of GABAergic interneurons. PMC10141498
mice Doxorubicin-induced cardiotoxicity (DIC) model intraperitoneal injection 1 mg/kg once daily for 2 weeks To explore the influence of ferroptosis induced by DIC injury on E-Exe preconditioning, results showed that Fer-1 significantly alleviated DIC injury PMC10878110
Rats FTL knockdown pregnant rat model Intraperitoneal injection 2 μM/kg Every two days until GD17.5 Blocking ferroptosis significantly reversed the shFTL-induced PE-like phenotypes, including improvements in glomerular morphological damage, 24-hour proteinuria, and blood pressure. PMC9706170
Balb/c mice EC-induced liver injury model Intraperitoneal injection 1 mg/kg 21 consecutive days Fer-1 pretreatment significantly increased and liver index in mice, decreased serum AST and ALT levels, alleviated EC-induced liver inflammation and oxidative stress, and restored the protein expression of GPX4 and Ferritin. PMC9142717
Mice Pulmonary ZnONPs exposure model Intraperitoneal injection 10 mg/kg Single dose, lasted for 3 days Significantly reversed ZnONPs-induced vascular injury PMC8726675
Mice Acute osteomyelitis model Intraperitoneal injection 10 mg/kg Once daily for 3 days To evaluate the inhibitory effect of Ferrostatin-1 on bacteria-induced ferroptosis in BMSCs in vivo. Results showed that Fer-1 significantly reduced the levels of lipid peroxides in BMSCs. PMC11497072
C57BL/6 mice NAFLD model induced by high-fat diet and chronic intermittent hypoxia Intraperitoneal injection 1 mg/kg Once daily for four weeks Inhibited ferroptosis and alleviated HFD and CIH-induced liver function injury and lipid accumulation PMC11538716
C57BL/6 mice Mtb H37Rv infection model Intraperitoneal injection 3 mg/kg Once daily from day 15 to day 28 post-infection Reduced pulmonary necrosis and bacterial load PMC6400546

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.81mL

0.76mL

0.38mL

19.06mL

3.81mL

1.91mL

38.12mL

7.62mL

3.81mL

References

 

Historical Records

Categories